Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Accumulated Expenses (2016 - 2020)

Historic Other Accumulated Expenses for AC Immune (ACIU) over the last 6 years, with Q1 2020 value amounting to $130264.7.

  • AC Immune's Other Accumulated Expenses changed N/A to $130264.7 in Q1 2020 from the same period last year, while for Mar 2020 it was $130264.7, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2018, which is 15004.95% up from last year.
  • Latest data reveals that AC Immune reported Other Accumulated Expenses of $130264.7 as of Q1 2020.
  • AC Immune's 5-year Other Accumulated Expenses high stood at $1.5 million for Q3 2017, and its period low was -$709484.2 during Q2 2017.
  • For the 4-year period, AC Immune's Other Accumulated Expenses averaged around $405995.3, with its median value being $372276.4 (2016).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first soared by 47067.06% in 2016, then tumbled by 35308.57% in 2017.
  • AC Immune's Other Accumulated Expenses (Quarter) stood at $817020.0 in 2016, then crashed by 43.18% to $464219.3 in 2017, then surged by 145.68% to $1.1 million in 2018, then plummeted by 88.58% to $130264.7 in 2020.
  • Its last three reported values are $130264.7 in Q1 2020, $1.1 million for Q4 2018, and $464219.3 during Q4 2017.